Aerosolized pentamidine prophylaxis against AIDS-related Pneumocystis carinii pneumonia and its short- and long-term effects on pulmonary function in the Japanese

Kaplan, 2002, Guidelines for preventing opportunistic infections among HIV-infected persons – 2002 Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America, MMWR (Recomm Rep), 51, 1 Hardy, 1992, A controlled trial of trimethoprimsulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome, N Engl J Med, 327, 1842, 10.1056/NEJM199212243272604 Pearson, 1985, Pentamidine for the treatment of Pneumocystis carinii pneumonia and other protozoal diseases, Ann Intern Med, 103, 782, 10.7326/0003-4819-103-5-782 Schneider, 1992, A controlled trial of aerosolized pentamidine or trimethoprim-sulfamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection, N Engl J Med, 327, 1836, 10.1056/NEJM199212243272603 Hirschel, 1991, A controlled study of inhaled pentamidine for primary prevention of Pneumocystis carinii pneumonia, N Engl J Med, 324, 1079, 10.1056/NEJM199104183241602 Ewig, 1996, Effect of long-term primary aerosolized pentamidine prophylaxis on breakthrough Pneumocystis carinii pneumonia, Eur Respir J, 9, 1006, 10.1183/09031936.96.09051006 Wei, 2001, Risk factors for prophylaxis failure in patients receiving aerosol pentamidine for Pneumocystis carinii pneumonia prophylaxis, Chest, 119, 1427, 10.1378/chest.119.5.1427 Montaner, 1991, Aerosol pentamidine for secondary prophylaxis of AIDS-related Pneumocystis carinii pneumonia: a randomized, placebo-controlled study, Ann Intern Med, 114, 948, 10.7326/0003-4819-114-11-948 Golden, 1993, A randomized comparison of once-monthly or twice-monthly highdose aerosolized pentamidine prophylaxis, Chest, 104, 743, 10.1378/chest.104.3.743 Rizzardi, 1995, Better efficacy of twice-monthly than monthly aerosolised pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with AIDS. An Italian multicentric randomised controlled trial, J Infect, 31, 99, 10.1016/S0163-4453(95)92035-8 Yamamoto, 2001, Serial pentamidine levels in bronchial epithelial lining fluid after aerosol administration, Respiration, 68, 506, 10.1159/000050559 Kennedy, 1992, Atypical roentgenographic manifestation of Pneumocystis carinii pneumonia, Arch Intern Med, 152, 1390, 10.1001/archinte.1992.00400190032008 Harrison, 1994, Bronchodilator pretreatment improves aerosol deposition uniformity in HIV-positive patients who cough while inhaling aerosolized pentamidine, Chest, 106, 421, 10.1378/chest.106.2.421 Wei, 1998, Effects of long-term aerosol pentamidine for Pneumocystis carinii prophylaxis on pulmonary function, Chest, 114, 742, 10.1378/chest.114.3.742 Ong, 1992, Efficacy and effects on pulmonary function tests of weekly 600 mg aerosol pentamidine as prophylaxis against Pneumocystis carinii pneumonia, Infection, 20, 136, 10.1007/BF01704600 Camus, 1991, Pulmonary tolerance of prophylactic aerosolized pentamidine in human immunodeficiency virus-infected patients, Chest, 99, 609, 10.1378/chest.99.3.609 Hiles, 1994, Inhalation toxicity of aerosolized pentamidine isethionate in rats and dogs, Fundam Appl Toxicol, 23, 382, 10.1006/faat.1994.1119